ArticleBMC cancer2022

Multinomial network meta-analysis using response rates: relapsed/refractory multiple myeloma treatment rankings differ depending on the choice of outcome.

Chrissy H Y van Beurden-Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.